PRINCETON, N.J.--(BUSINESS WIRE)--Certara®, the global biosimulation technology-enabled drug development company, today announced the release of version 15 of its Simcyp® Population-based Simulator.
Simcyp, now part of Certara, is pleased to announce the release of Version 12 of its Population-based Simulator, the pharmaceutical industry’s most sophisticated ...
Simcyp Limited, the leader in predictive pharmacokinetics, has released Version 8.0 of the ‘Simcyp Population-based ADME Simulator’, an advanced platform for the modelling and simulation of drug ...
Certara, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, announced the launch of version 18 of its Simcyp Population-based ...
Scientists at the University of Exeter have created an online simulation which will help people understand how individual actions impact the spread of diseases. Simuland: Beat the Epidemic is a ...
PRINCETON, N.J.--(BUSINESS WIRE)--Certara®, the leading provider of decision support technology and consulting services for optimizing drug development and improving health outcomes, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results